BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26591311)

  • 21. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
    Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
    J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adjuvant regional chemotherapy after resection of liver metastases of primary colorectal tumors].
    Lorenz M; Hottenrott C; Encke A
    Zentralbl Chir; 1993; 118(5):279-89. PubMed ID: 8322538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Strategy of liver resection during chemotherapy for otherwise unresectable colorectal metastases].
    Tanaka K; Kumamoto T; Takeda K; Nojiri K; Endo I
    Nihon Rinsho; 2013 Jul; 71(7):1303-9. PubMed ID: 23961684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future directions in the use of antiangiogenic agents in patients with colorectal cancer.
    Hoff PM
    Semin Oncol; 2004 Dec; 31(6 Suppl 17):17-21. PubMed ID: 15696026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neoadjuvant chemotherapy for advanced colorectal cancer].
    Ohira G; Miyauchi H; Suzuki K; Nishimori T; Tohma T; Narushima K; Matsubara H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1626-8. PubMed ID: 24393870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary 2008: 25 or 50 years later?
    Saletti P; Sessa C; Cavalli F
    J Clin Oncol; 2008 Oct; 26(30):4854-5. PubMed ID: 18794536
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver metastases of colorectal cancer: medical treatments.
    Pasetto LM; Rossi E; Monfardini S
    Anticancer Res; 2003; 23(5b):4245-56. PubMed ID: 14666634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases.
    Okuno K; Shigeoka H; Lee YS; Son E; Kayama H; Nakai T; Koh K; Yasutomi M
    Hepatogastroenterology; 1996; 43(9):688-91. PubMed ID: 8799416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
    Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
    Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
    Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic adjuvant hepatic arterial infusion chemotherapy reduced hepatic metastases from Stage III colorectal cancer after curative resection.
    Feng WM; Tang CW; Huang SX; Zheng YY; Bao Y; Wang Y; Tao YL
    Hepatogastroenterology; 2012 Jun; 59(116):1087-90. PubMed ID: 22328287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing].
    Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO
    Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highlights from: 38th annual meeting of the American Society of Clinical Oncology.
    Clin Colorectal Cancer; 2002 Aug; 2(2):73-7. PubMed ID: 12453319
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in the treatment of colon cancer.
    Xu R; Zhou B; Fung PC; Li X
    Histol Histopathol; 2006 Aug; 21(8):867-72. PubMed ID: 16691539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highlights from: 39th Annual Meeting of the American Society of Clinical Oncology: Chicago, Illinois. May 31 to June 3, 2003.
    Clin Colorectal Cancer; 2003 Aug; 3(2):78-84. PubMed ID: 12952561
    [No Abstract]   [Full Text] [Related]  

  • 39. [New treatments in immuno-oncology: a revolution and a formidable scientific and clinical challenge].
    Champiat S; Soria JC
    Med Sci (Paris); 2017; 33(6-7):563-564. PubMed ID: 28990546
    [No Abstract]   [Full Text] [Related]  

  • 40. Highlights from 40th Annual Meeting of the American Society of Clinical Oncology New Orleans, LA, June 2004.
    Lee D
    Clin Colorectal Cancer; 2004 Sep; 4(3):154-8. PubMed ID: 15377398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.